Managing Microbial Risk – A Quality by Design Approach
Posted on March 21, 2014
By: Linda Skowronsky, Senior Development Microbiologist
GSK
Introduction According to World Health Organization, good pharmaceutical quality represents “an acceptably low risk of failing to achieve good clinical results”1; in other words, low risk of harm to user. For a microbiologist, managing microbial quality can be an overwhelming task due to the ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
GSK, microbial, Microbial Risk, Microbial Risk Assessment (MRA), Microbiological Investigations, microbiology, QbD, WHO
Related Product Videos
The Milliflex® Rapid System for Sterility Testing
GENIII Microbial ID Assay - Biolog
Related Products
Merck Millipore celebrates 40 years of first class sterility testing solutions
VITEK®MS: The most rapid solution for identification of microorganisms - bioMérieux
Related Technical Papers
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
